Abdullah Esmail

30PUBLICATIONS
40CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisPredictive and prognostic markersAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Jul 15, 2026
Comprehensive Safety and Efficacy Evaluation of Immunotherapy Combination Approaches Versus Tyrosine Kinase Inhibitor Monotherapy as First-Line Treatment of Hepatocellular Carcinoma: A Network and Individual Patient Data (IPD) Meta-Analysis.

|Dec 30, 2025
Atezolizumab Plus Bevacizumab Combination Therapy in Unresectable Hepatocellular Carcinoma: An Institutional Experience.

Abdullah Esmail, Yazan Hamadneh, Bayan Khasawneh

|Oct 23, 2025
Reply to: Beyond Detection: Addressing Threshold Definition and Clinical Integration of Circulating Tumor DNA in Post-Curative Hepatocellular Carcinoma.

Maen Abdelrahim, Abdullah Esmail

|Sep 15, 2025
Tumor-informed circulating tumor DNA assay for surveillance post-liver transplantation in patients with hepatocellular and cholangiocarcinoma.

Maen Abdelrahim, Ashton A Connor, Abdullah Esmail

|Jul 25, 2025
Idiopathic Duodenal Hematoma: A Case Report and Literature Review.

Ebtesam Al-Najjar, Abdullah Esmail, Bayan Khasawneh

|Jul 25, 2025
An 81-Year-Old Geriatric Patient with Metastatic Pancreatic Cancer Demonstrating Excellent Response and Well Tolerance to NALIRIFOX: A Case Report and Literature Review.

Bayan Khasawneh, Abdullah Esmail, Ebtesam Al-Najjar

Pageof 5

Frequent Collaborators

4 joint publications

Godsfavour Umoru

4 joint publications

Maen Abdelrahim

3 joint publications

Ala Abudayyeh

2 joint publications

Ashish Saharia